Proliferation of cancer cells despite CDK2 inhibition

Cancer Cell

Volumn 3, Issue 3, 2003, Pages 233-245

  Tetsu, Osamu ^a   McCormick, Frank ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; AG 12275; ANTISENSE OLIGONUCLEOTIDE; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PONASTERONE A; PROTEIN P21; PROTEIN P27; RNA; UNCLASSIFIED DRUG; 1,3 BUTADIENE DERIVATIVE; 2-(2-CHLORO-4-IODOPHENYLAMINO)-N-CYCLOPROPYLMETHOXY-3,4-DIFLUOROBENZAMIDE; BENZAMIDE DERIVATIVE; CDK2 PROTEIN, HUMAN; CDK4 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; CYCLINE; DRUG DERIVATIVE; ECDYSTERONE; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; NITRILE; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UTERINE CERVIX CARCINOMA; BIOLOGICAL MODEL; CELL CULTURE; CELL DIVISION; COLON TUMOR; DRUG ANTAGONISM; GENETICS; HELA CELL; METABOLISM; MUTATION; SITE DIRECTED MUTAGENESIS;

BENZAMIDES; BUTADIENES; CDC2-CDC28 KINASES; CELL DIVISION; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; CYCLINS; ECDYSTERONE; ENZYME INHIBITORS; FEMALE; G1 PHASE; HELA CELLS; HUMANS; MAP KINASE KINASE KINASES; MODELS, BIOLOGICAL; MUTAGENESIS, SITE-DIRECTED; MUTATION; NITRILES; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED;

EID: 0041327168     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00053-9     Document Type: Article

References (56)

1. Agami R., Bernards R. Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell. 102:2000;55-66.
2. Bischoff J.R., Anderson L., Zhu Y., Mossie K., Ng L., Souza B., Schryver B., Flanagan P., Clairvoyant F., Ginther C., et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17:1998;3052-3065.
3. Blain S.W., Montalvo E., Massague J. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J. Biol. Chem. 272:1997;25863-25872.
4. Bouchard C., Thieke K., Maier A., Saffrich R., Hanley-Hyde J., Ansorge W., Reed S., Sicinski P., Bartek J., Eilers M. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J. 18:1999;5321-5333.
5. Brugarolas J., Moberg K., Boyd S.D., Taya Y., Jacks T., Lees J.A. Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation. Proc. Natl. Acad. Sci. USA. 96:1999;1002-1007.
6. Buolamwini J.K. Cell cycle molecular targets in novel anticancer drug discovery. Curr. Pharm. Des. 6:2000;379-392.
7. Burri N., Shaw P., Bouzourene H., Sordat I., Sordat B., Gillet M., Schorderet D., Bosman F.T., Chaubert P. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab. Invest. 81:2001;217-229.
8. Cheng M., Olivier P., Diehl J.A., Fero M., Roussel M.F., Roberts J.M., Sherr C.J. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1999;1571-1583.
9. Coleman K.G., Sedman S.A., Brinkley P., Price S., Webster K.R. Identification of CDK4 sequences involved in cyclin D1 and p16 binding. J. Biol. Chem. 272:1997;18869-18874.
10. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:2000;95-105.
11. Dirks P.B., Patel K., Hubbard S.L., Ackerley C., Hamel P.A., Rutka J.T. Retinoic acid and the cyclin dependent kinase inhibitors synergistically alter proliferation and morphology of U343 astrocytoma cells. Oncogene. 15:1997;2037-2048.
12. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:1998;18623-18632.
13. Gottschalk A.R., Basila D., Wong M., Dean N.M., Brandts C.H., Stokoe D., Haas-Kogan D.A. p27Kip1 is required for PTEN-induced G1 growth arrest. Cancer Res. 61:2001;2105-2111.
14. Heise C., Sampson-Johannes A., Williams A., McCormick F., Von Hoff D.D., Kirn D.H. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat. Med. 3:1997;639-645.
15. Herrera R.E., Sah V.P., Williams B.O., Makela T.P., Weinberg R.A., Jacks T. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16:1996;2402-2407.
16. Hinds P.W., Mittnacht S., Dulic V., Arnold A., Reed S.I., Weinberg R.A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell. 70:1992;993-1006.
17. Hu B., Mitra J., van den Heuvel S., Enders G. S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells. Mol. Cell. Biol. 21:2001;2755-2766.
18. Jiang H., Chou H.S., Zhu L. Requirement of cyclin E-Cdk2 inhibition in p16(INK4a)-mediated growth suppression. Mol. Cell. Biol. 18:1998;5284-5290.
19. Katayose Y., Kim M., Rakkar A.N., Li Z., Cowan K.H., Seth P. Promoting apoptosis. a novel activity associated with the cyclin-dependent kinase inhibitor p27 Cancer Res. 57:1997;5441-5445.
20. Kato J.Y., Matsuoka M., Strom D.K., Sherr C.J. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol. Cell. Biol. 14:1994;2713-2721. a.
21. Kato J.Y., Matsuoka M., Polyak K., Massague J., Sherr C. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell. 79:1994;487-496. b.
22. Kitagawa M., Higashi H., Jung H.K., Suzuki-Takahashi I., Ikeda M., Tamai K., Kato J., Segawa K., Yoshida E., Nishimura S., Taya Y. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15:1996;7060-7069.
23. Koh J., Enders G.H., Dynlacht B.D., Harlow E. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature. 375:1995;506-510.
24. Kwon T.K., Nordin A.A. Overexpression of cyclin E and cyclin-dependent kinase inhibitor (p27Kip1). effect on cell cycle regulation in HeLa cells Biochem. Biophys. Res. Commun. 238:1997;534-538.
25. Lukas J., Bartkova J., Rohde M., Strauss M., Bartek J. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15:1995;2600-2611. a.
26. Lukas J., Parry D., Aagaard L., Mann D.J., Bartkova J., Strauss M., Peters G., Bartek J. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature. 375:1995;503-506. b.
27. Madema R.H., Herrera R.E., Lam F., Weinberg R.A. Growth suppression by p16 ink4 requires functional retinoblastoma protein. Proc. Natl. Acad.Sci. USA. 92:1995;6289-6293.
28. Malumbres M., Barbacid M. To cycle or not to cycle. A critical decision in cancer Nat. Rev. Cancer. 1:2001;222-231.
29. Matsuoka M., Kato J.Y., Fisher R.P., Morgan D.O., Sherr C.J. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol. Cell. Biol. 14:1994;7265-7275.
30. McConnell B.B., Gregory F.J., Stott F.J., Hara E., Peters G. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. Mol. Cell. Biol. 19:1999;1981-1989.
31. Naruse I., Hishino H., Dobashi K., Minato K., Saito R., Mori M. Over-expression of p27 Kip1 induces growth arrest and apoptosis mediated by changes of pRB expression in lung cancer cell lines. Int. J. Cancer. 88:2000;377-383.
32. Nigg E.A. Mitotic kinases as regulators of cell division and its checkpoints. Nat. Rev. Mol. Cell Biol. 2:2001;21-32.
33. Ohtsubo M., Theodoras A.M., Schumacher J., Roberts J.M., Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 121:1995;2612-2624.
34. Okuda M., Horn H.F., Tarapore P., Tokuyama Y., Smulian A.G., Chan P.K., Knudsen E.S., Hofmann I.A., Snyder J.D., Bove K.E., Fukasawa K. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell. 103:2000;127-140.
35. Pagano M.R., Pepperkok R., Verde F., Ansonge W., Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J. 11:1992;961-971.
36. Perez-Roger I., Kim S.H., Griffiths B., Sewing A., Land H. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). EMBO J. 18:1999;5310-5320.
37. Polyak K., Kato J.Y., Solomon M.J., Sher C.J., Massague J., Robert J.M., Koff A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8:1994;9-22.
38. Reed S.I. Control of the G1/S transition. Cancer Surveys 29, M. Kastern, ed., Checkpoint Controls and Cancer. 1997;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 7-23.pp.
39. Reynisdottir I., Massague J. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11:1997;492-503.
40. Sebolt-Leopold J.S., Dudley D.T., Herrera R., Van Becelaere K., Wiland A., Gowan R.C., Tecle H., Barrett S.D., Bridges A., Przybranowski S., et al. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat. Med. 5:1999;810-816.
41. Sherr C.J., McCormick F. The RB and p53 pathways in cancer. Cancer Cell. 2:2002;103-112.
42. Sherr C.J., Roberts J.M. CDK inhibitors. positive and negative regulators of G1-phase progression Genes Dev. 13:1999;1501-1512.
43. Stucke V.M., Sillje H.H., Arnaud L., Nigg E.A. Human Mps1 kinase is required for the spindle assembly checkpoint but not for centrosome duplication. EMBO J. 21:2002;1723-1732.
44. Swarbrick A., Lee C.S., Sutherland R.L., Musgrove E.A. Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells. Mol. Cell. Biol. 20:2000;2581-2591.
45. Tarapore P., Horn H.F., Tokuyama Y., Fukasawa K. Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway. Oncogene. 20:2001;3173-3184.
46. Tetsu O., McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:1999;422-426.
47. Tsai L.-H., Lees E., Faha B., Harlow E., Riabowol K. The cdk kinase is required for the G1-to-S transition in mammalian cells. Oncogene. 8:1993;1593-1602.
48. Tsutsui T., Hesab B., Moons D.S., Pandolfi P.P., Hansel K.S., Koff A., Kiyokawa H. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27 (Kip1) activity. Mol. Cell. Biol. 19:1999;7011-7019.
49. Toogood P.L. Cyclin-dependent kinase inhibitors for treating cancer. Med. Res. Rev. 6:2001;487-498.
50. Toyoshima H., Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell. 78:1994;67-74.
51. van den Heuvel S., Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science. 262:1993;2050-2054.
52. Vlach J., Hennecke S., Amati B. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J. 16:1997;5334-5344.
53. Wakita K., McCormick F., Tetsu O. Method for screening ecdysone-inducible stable cell lines. Biotechniques. 31:2001;414-418.
54. Yang H.-Y., Shao R., Hung M.-C., Lee M.-H. p27 Kip1 inhibits HER2/neu-mediated cell growth and tumorigenesis. Oncogene. 20:2001;3695-3702.
55. Zarkowska T., Mittnacht S. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J. Biol. Chem. 272:1997;12738-12746.
56. Zhou H., Kuang J., Zhong L., Kuo W.L., Gray J.W., Sahin A., Brinkley B.R., Sen S. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet. 20:1998;189-193.